Kronox Lab Sciences IPO opens for subscription. Should you bid?

Kronox Lab Sciences IPO, consisting solely of an offer for sale, presents potential for sustainable growth, with analysts recommending subscription. The issue, open until June 5, allocates 50% to QIBs, 15% to NIIs, and 35% to retail investors.

For more details: Read More